Page last updated: 2024-10-31

mianserin and Ataxia

mianserin has been researched along with Ataxia in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Steroids were restarted and his ataxia stabilized."1.46JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. ( Angeles, MR; Bucelli, RC; Clifford, DB; Dang, X; Koralnik, IJ; Kuhlmann, FM; Major, EO; Ryschkewitsch, CF; Schmidt, RE; Schwetye, KE; Soleimani-Meigooni, DN, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soleimani-Meigooni, DN1
Schwetye, KE1
Angeles, MR1
Ryschkewitsch, CF1
Major, EO1
Dang, X1
Koralnik, IJ1
Schmidt, RE1
Clifford, DB1
Kuhlmann, FM1
Bucelli, RC1

Other Studies

1 other study available for mianserin and Ataxia

ArticleYear
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.
    Journal of neurovirology, 2017, Volume: 23, Issue:1

    Topics: Aged; Ataxia; Chronic Disease; Hamartoma Syndrome, Multiple; Humans; Immunocompromised Host; Immunog

2017
chemdatabank.com